Buy & Sell Gilead Sciences, Inc. (GILD) – Gilead Sciences, Inc. Price Today
HawkEye 360 prices IPO at $26, raising $416M ahead of NYSE debut as space analytics demand grows
HawkEye 360, a space analytics company based in Virginia, set its IPO price at $26 per share, selling 16 million shares to raise approximately $416 million before fees. The company will begin trading on the New York Stock Exchange under the ticker "H...
Hubbell posts 8% organic growth and margin gains but cautious on valuation despite strong M&A moves
Hubbell reported 8% organic revenue growth and improved margins in Q1, driven by strong operational momentum and strategic acquisitions like NSI Industries, which is expected to boost EBITDA margins to 26%-27% in the next 2-3 years. Despite these pos...
ENR FutureTech 2026 sets record attendance, showcasing robotics and AI transforming construction industry.
ENR FutureTech 2026, the leading construction technology conference, concluded with record attendance and sold-out sponsorships, highlighting innovations like autonomous excavators and AI-driven project management. Industry leaders and tech innovator...
Halper Sadeh LLC investigates fairness of deals for HLX, OGN, XOMA, and RMAX shareholders.
Halper Sadeh LLC is investigating whether shareholders of Helix Energy Solutions (HLX), Organon & Co. (OGN), XOMA Royalty Corporation (XOMA), and RE/MAX Holdings (RMAX) are receiving fair treatment in their companies' recent mergers and sales. The fi...
Zealand Pharma advances obesity drugs with Phase 3 trials and launches $200M share buy-back program
Zealand Pharma reported strong Q1 2026 results, advancing its obesity treatments petrelintide and survodutide into Phase 3 trials after positive Phase 2 and 3 data showed significant weight loss and good tolerability. The company also established a n...
Occidental Petroleum stays a Buy with strong balance sheet and growth plans despite market risks.
Occidental Petroleum (OXY) remains a Buy due to a strengthened balance sheet, ongoing debt repayments nearing targets, and a diversified low-cost portfolio. The company’s 2026 guidance includes $5.5–$5.9 billion in capital expenditures, $750 million ...
Tempus AI shows long-term promise with strong oncology testing and expanding market despite mixed Q1 results.
Tempus AI reported mixed Q1 results with strong oncology testing but weakness in hereditary testing, slower revenue growth, yet improved gross margins and narrowing losses. The company achieved a record $1.1 billion total contract value and 126% net ...
Tesla recalls 218,000+ cars over delayed rearview camera images risking crashes
Tesla is recalling over 218,000 Model 3, Model Y, Model S, and Model X vehicles due to delayed rearview camera images that could increase crash risk. The affected cars, featuring hardware version 3, may have a delayed camera display when reversing, r...
Snap and Perplexity end AI integration plans for Snapchat, citing misaligned product goals.
Snap and Perplexity have mutually ended their partnership to integrate Perplexity's AI answer engine into Snapchat, as the collaboration did not align with their product goals. Initially announced in November 2025, the deal involved Perplexity paying...
Adyen's payment volume jumps 21% in Q1, showing strong consumer spending amid economic uncertainty.
Adyen reported a 21% year-over-year increase in processed payment volume for Q1 2026, reaching €382 billion ($449 billion), driven by growth across Digital, Unified Commerce, and Platforms segments. This surge highlights resilient consumer spending d...